World AMR Awareness Week

World AMR Awareness Week

Observed on 18 - 24 November 2024

WHO Nepal/A.Maharjan
A health-care worker showcasing medications used for the treatment of multi-drug-resistant tuberculosis in Bagmati Province, Nepal
© Credits

Educate. Advocate. Act now.


Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial agents. As a result of drug resistance, antibiotics and other antimicrobial agents become ineffective and infections become difficult or impossible to treat, increasing the risk of disease spread, severe illness and death.

The World AMR Awareness Week (WAAW) is a global campaign to raise awareness and understanding of AMR and promote best practices among One Health stakeholders to reduce the emergence and spread of drug-resistant infections. WAAW is celebrated from 18-24 November every year.

The theme for the World AMR Awareness Week (WAAW) 2024 is “Educate. Advocate. Act now.” This theme was chosen based on feedback from an online survey among stakeholders from the human, animal, plant, and environmental health sectors, which collected nearly 200 responses globally.

Antimicrobial resistance (AMR) is a pressing global health and socioeconomic crisis. It has significant impacts on human and animal health, food production and the environment. Drug-resistant-pathogens pose a threat to everyone, everywhere. Yet, much more can be done to raise public and stakeholder awareness.  Therefore, this year’s theme calls on the global community to educate stakeholders on AMR, advocate for bold commitments and take concrete actions in response to AMR. The 2024 UNGA High-level Meeting on AMR and the fourth Global High-Level Ministerial Conference on AMR, for instance, provide a critical window of opportunity for political and financial commitments as well as increased accountability in response to AMR. Stronger political leadership, advocacy and accountability are needed at all levels and the time to act is now. 

A message by WHO Representative to Nepal on World AMR Awareness Day

Campaign Materials

It's time for action_World Hepatitis Day 2024_Digital Standee_ENG
It's time for action_World Hepatitis Day 2024_Digital Standee_ENG
It's time for action_World Hepatitis Day 2024_Digital Standee_ENG
It's time for action_World Hepatitis Day 2024_Digital Standee_ENG
It's time for action_World Hepatitis Day 2024_Digital Standee_ENG
It's time for action_World Hepatitis Day 2024_Digital Standee_ENG

Fact Sheets

News from Nepal

Global News

Related publications

The selection and use of essential medicines, 2025: WHO AWaRe (Access, Watch, Reserve) classification of antibiotics for evaluation and monitoring of use

he AWaRe classification is intended as a tool for monitoring antibiotic consumption, defining targets and monitoring the effects of stewardship policies...

In vitro diagnostic tests for serious bacterial infection, including neonatal sepsis, among infants aged 0–59 days: target product profile

An estimated 2.3 million newborns die each year. Low- and middle-income countries bear the greatest mortality burden, with sepsis contributing 15%. It...

Bibliography of Scientific Publications on Antimicrobial Resistance from South-East Asia Region (‎1990-2010)‎

Antimicrobial resistance (AMR) is now the most important challenge being faced by humanity in its fight against infectious diseases. The emergence...

Global Antimicrobial Resistance and Use Surveillance System (‎GLASS)‎ report: antibiotic use data for 2022

This Global Antimicrobial Resistance and Use Surveillance System (GLASS) report describes global progress in GLASS-AMU surveillance and antibiotic use...

Antimicrobial resistance prevention and education in schools: a brief for education policy-makers and school practitioners

Antimicrobial resistance (AMR) poses a threat to global health, food security and achieving the 2030 Sustainable Development Goals (SDGs). Tackling AMR...

Antifungal agents in clinical and preclinical development: overview and analysis

This report presents the first World Health Organization (WHO) analysis of antifungal agents in clinical and preclinical development. It covers systemic...

Related campaigns